EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Second Breast‐Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes

Cezara Cheptea iD, Youlia Kirova iD, Radu Iulian Mitrica, Mihaela Badea iD, Pierre Loap iD

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70718 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Cezara Cheptea und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Mastectomy, Segmental, Patient Selection, Re-Irradiation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Local recurrence after primary breast cancer treatment remains a complex clinical scenario in patients previously treated with breast‐conserving therapy and radiotherapy. For decades, salvage mastectomy was considered the standard treatment for ipsilateral breast tumor recurrence, largely because of concerns about local control after repeat lumpectomy and cumulative toxicity after reirradiation. This paradigm has progressively changed. Retrospective comparative series, prospective Phase II data, large multicenter brachytherapy cohorts, and population‐based analyses suggest that second breast‐conserving treatment combined with reirradiation can achieve favorable local control and survival in carefully selected patients, without an apparent survival impact compared with mastectomy. The strongest evidence supports partial breast reirradiation after complete resection of small, unifocal recurrences occurring after a sufficient interval from prior radiotherapy. External beam radiotherapy, multicatheter brachytherapy, and intraoperative radiotherapy each offer distinct technical advantages, toxicity profiles, and levels of evidence. Across modalities, outcomes are most favorable in patients with limited disease, complete resection, long interval from initial treatment, and favorable tumor biology, whereas early recurrence, gross residual disease, skin or chest wall involvement, and adverse molecular subtype are associated with poorer outcomes. Risk stratification tools, including the GEC‐ESTRO APBI classification and TAM score, may help refine patient selection, but practice remains heterogeneous and cumulative dose constraints are not standardized. Future studies should define optimal reirradiation techniques, normal tissue constraints, integration with modern systemic therapies, and patient‐reported outcomes. Second breast‐conserving treatment should therefore be viewed as a personalized alternative to salvage mastectomy in selected patients, rather than as a universal replacement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalMastectomy, SegmentalPatient SelectionRe-IrradiationBreast NeoplasmsHumansFemaleTreatment OutcomeSalvage TherapyBrachytherapy

Stichwörter der Autor:innen

breast cancer recurrencebreast reirradiationipsilateral breast tumor recurrencepatient selectionsecond breast‐conserving treatment

Autor:innen und Institutionen

  • Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
  • University of Brasov, Brasov, Romania.
  • Department of Radiation Oncology, Institut Curie, Paris, France.
  • Advanced Therapy in Radiation Oncology and Molecular Imaging Characterisation (ATOMIC), Institut Curie, Orsay, France.
  • Department of Radiotherapy II, Bucharest Institute of Oncology, Bucharest, Romania.

ORCID-Profile: Cezara Cheptea, Youlia Kirova, Mihaela Badea, Pierre Loap

Zitieren

APA

Cheptea, C., Kirova, Y., Mitrica, R. I., Badea, M., & Loap, P. (2026). Second Breast‐Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes. International Journal of Cancer. https://doi.org/10.1002/ijc.70718

Vancouver

Cheptea C, Kirova Y, Mitrica RI, Badea M, Loap P. Second Breast‐Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes. International Journal of Cancer. 2026. doi:10.1002/ijc.70718

BibTeX
@article{Cheptea2026,
  author = {Cheptea, Cezara and Kirova, Youlia and Mitrica, Radu Iulian and Badea, Mihaela and Loap, Pierre},
  title = {Second Breast‐Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70718}
}
Kostenlos starten →